中文 | English
Return
Total: 89 , 1/9
Show Home Prev Next End page: GO
Author:(De-Long ZHAO)

1.The study of correlation between anti-cyclic citrnllinated peptide antibody and rheumatoid arthritis

Xi-De LIU ; Long CAI ; Zhao-Dong LI ; Jin-Lu ZHANG ;

Chinese Journal of Rheumatology 2000;0(06):-

2.Effect of Endotoxin on the expression of peroxisome proliferator-activated receptor alpha in the development of nonalcoholic steatohepatitis in rats.

Xia LI ; De Wu HAN ; Long Feng ZHAO ; Lei YIN

Chinese Journal of Hepatology 2005;13(2):89-91

5.Clinical effect of anti-VEGF drugs combined with laser therapy for DME patients

Li, YIN ; De-Long, ZHANG ; Qian, REN ; Xian, SU ; Hua, YU ; Li, LI ; Rui-Xue, SUN ; Zhao-Hui, SUN

International Eye Science 2017;17(6):1116-1118

6.Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-iR mice and its mechanism.

Sheng-Long ZHU ; Zhen-Yu ZHANG ; Gui-Ping REN ; Xian-Long YE ; Lei MA ; Dan YU ; Miao-Miao HAN ; Jing-Zhuang ZHAO ; Tian-Yuan ZHANG ; De-Shan LI

Acta Pharmaceutica Sinica 2013;48(12):1778-1784

7.Anatomical and clinical study of the supinator syndrome evoked embitterment test.

Long-xi REN ; Qiu-tie BAI ; Ting-cai ZHANG ; Yan-song WANG ; Wei ZHAO ; Min ZHANG ; De-long LIU

Chinese Journal of Surgery 2004;42(8):465-468

8.Changes in mast cells and hepatic expression of c-kit and stem cell factor in the rat model of chronic hepatitis.

Hong LI ; Long-feng ZHAO ; Yan-qin HAO ; Lei YIN ; Yuan-chang ZHAO ; De-wu HAN

Chinese Journal of Hepatology 2013;21(11):869-873

9.Effect of phenylhexyl isothiocyanate on inducing apoptosis of multiple myeloma cells in vitro.

Quan-Yi LU ; Zhao WANG ; De-Long LIU

Journal of Experimental Hematology 2008;16(1):89-92

10.Role of CaN-NFATc3 pathway in abdominal aorta restenosis following ballon dilatation in rats.

Xiao-Yun LI ; Long-Gen XIONG ; De-En LI ; Lu-Ning ZHAO ; Qi DONG

Journal of Southern Medical University 2016;36(11):1561-1565

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 89 , 1/9 Show Home Prev Next End page: GO